CCL5 and breast carcinoma: In bc-GenExMiner (V4.1 DNA chip database), the univariate Cox regression analysis also showed that CCL5 (p = 0.0335, HR = 0.94) in metastatic relapse breast cancer had a positive effect on prognosis [61].